DexCom, Inc. - Common Stock (NQ:DXCM)

Their headwinds won't last forever.

2 Beaten-Down Growth Stocks You Might Regret Not Buying ↗

October 05, 2024

The company's game-changing technology could improve the lives of hundreds of millions of patients.

Is DexCom a Millionaire Maker? ↗

October 05, 2024

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today ↗

September 30, 2024

Via Benzinga

What the Options Market Tells Us About DexCom ↗

September 26, 2024

Via Benzinga

Is DexCom a Millionaire Maker? ↗

September 25, 2024

It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

October 02, 2024

From Faruqi & Faruqi LLP

Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.

Down More Than 50%, Is DexCom Stock a Bargain Now? ↗

October 02, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm

October 01, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

NASDAQ:DXCM, a strong growth stock, setting up for a breakout. ↗

September 19, 2024

Via Chartmill

ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

September 30, 2024

From The Rosen Law Firm PA

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

September 30, 2024

From Bernstein Liebhard LLP

Sometimes, a discounted stock can present a valuable opportunity.

2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now ↗

September 30, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024

September 29, 2024

Via NewMediaWire

Topics Lawsuit

DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024

September 29, 2024

NEW YORK, NY - (NewMediaWire) - September 29, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM)...

Via TheNewswire.com

Topics Lawsuit

ROSEN, A LONGSTANDING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

September 27, 2024

From The Rosen Law Firm PA

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 26, 2024

Kirby McInerney LLP Notifies Investors of Lead Plaintiff Deadline in Dexcom Inc. (DXCM) Securities Class Action

September 26, 2024

From Kirby McInerney LLP

DexCom Inc. October 21, 2024 Lead Plaintiff Deadline – DXCM Investors Should Contact Robbins LLP for Information

September 26, 2024

From Robbins LLP

Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.

September 26, 2024

From DexCom, Inc.

Via Business Wire

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

September 25, 2024

From Faruqi & Faruqi LLP

Two key uncertainties make the prospect of buying it today riskier than is desirable.

DexCom Is Great. Here's Why You Shouldn't Buy It. ↗

September 25, 2024

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against DexCom, Inc. (DXCM) – Deadline is October 21, 2024

September 24, 2024

From Kaplan Fox & Kilsheimer LLP

Via Business Wire

Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap

September 23, 2024

From DexCom, Inc.

Via Business Wire

DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline

September 23, 2024

From Bernstein Liebhard LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 22, 2024

ROSEN, A RANKED AND LEADING FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

September 21, 2024

From The Rosen Law Firm PA

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom

September 19, 2024

From Faruqi & Faruqi LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm

September 18, 2024